G43.0 G43.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria are as follows: - The presence of migraine since at least six months - The presence of an average migraine frequency of at least two attacks per months. At least one of these two attacks should last more than a day. - Konstant dose of a pharmacological prophylaxis (.i.e. Propanolol, Metoprolol, Topiramat und Flunarizin) over three month prior to start of the study - Willingness to accept the requirements of the intervention
Exclusion criteria
Exclusion criteria: In addition we defined the following exclusion criteria: - The presence of a life-threatening disease as well as presence of severe psychiatric disorders and/or addiction which seriously hinder interpersonal contact - Overuse of acute migraine medication potentially posing the risk of medication-induced headache (i.e. consumption of triptans on more of 10 day per months and consumption of simple analgetics on more than 15 days per month) - Intention to start another pain treatment or a psychotherapy or to participate in other clinical studies during the duration of the trial - Having a regular practice of meditation (> 1x per week) or Yoga (> 2x per week) as well as having participated in a MBSR- or MBCT-intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| migraine related disability assessed by headache diaries for three times for 4 weeks (intervention group: pre, post, 9-months-follow-up from baseline; control group: pre and post according to the waiting period and post2 according to the intervention that followed) by means of an eleven-scale numerical analogue scale (no impairment - complete impairment) | — |
Secondary
| Measure | Time frame |
|---|---|
| migraine specific variables assessed by headache diaries for three times for 4 weeks (intervention group: pre, post, 9-months-follow-up from baseline; control group: pre and post according to the waiting period and post2 according to the intervention that followed) - pain intensity (during the attack) - migraine frequency (days per month), - medication consumption (days per month) psychological variables assessed by questionnaires for three times (intervention group: pre, post, 9-months-follow-up from baseline; control group: pre and post according to the waiting period and post2 according to the intervention that followed) - perceived stress (Perceived Stress Questionnaire, PSQ) - depressivity (Hospital Anxiety and Depression Scale, HADS-D) - anxiety (Hospital Anxiety and Depression Scale, HADS-D) mediator variables assessed by questionnaires for three times (intervention group: pre, post, 9-months-follow-up from baseline; control group: pre and post according to the waiting period and post2 according to the intervention that followed) - rumination (Fragebogen zur Dysfunkt. u. Funkt. Selbstaufmerksamkeit DFS - Skala Dysfunkt. Selbstaufmerksamkeit) - emotional reactivity (Stressreaktivitätsskala SRS) - mindfulness (Freiburger Fragebogen zur Achtsamkeit FFA) - self-compassion (Self Compassion Scale SCS) - catastrophizing (Fragebogen zu Selbstinstruktionen in Schmerzsituationen) - self-efficacy (Fragebogen zur Schmerzregulation FSR) | — |
Countries
Germany
Contacts
Sektion Komplementärmedizinische Evaluationsforschung Zentrum für Psychische Erkrankungen Klinik für Psychosomatische Medizin und Psychotherapie Universitätsklinikum Freiburg